← SynDRA
VATINOXAN
SynDRA canonical compound SYN0039795 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | ADRA2A |
| Mechanism of action | adrenergic receptor antagonist |
All known targets
Mechanisms of action (all sources)
- adrenergic receptor antagonist
Cross-references
Synonyms
- L-659066
- MK 467
- vatinoxan hydrochloride
- L659066
- MK-467
- MK-467 FREE BASE
- mk-467 free base
- L-659,066
- vatinoxanum
- RefChem:193869
- Vatinoxan (USAN)
- VATINOXAN [USAN]
- 1]benzofuro[2,3-a]quinolizine-
- VATINOXAN [INN]
- UNII-342EYN0QFD
- 2,4'-imidazolidin]-3'-yl]ethyl}methanesulfonamide
- orb1699021
- SCHEMBL9866468
- GTBKISRCRQUFNL-OXJNMPFZSA-N
- N-{2-[(2R,12bS)-2'-oxo-1,3,4,6,7,12bhexahydrospiro[[
- AKOS040749743
- HY-19057
- CS-0014766
- NS00134334
- D11320
- T29098
- L 659066
- MK-467 free base
- T13285
- VATINOXAN HYDROCHLORIDE [USAN]
- MS-28291
- CS-0018087
- RefChem:58019
- C20H27ClN4O4S
- G13425
- UNII-66932R910R
- D11321
- Vatinoxan hydrochloride (USAN)
Look up VATINOXAN in the interactive SynDRA portal →